Illumina, INC miseq silver support. Includes full coverage for parts, labor, and travel. Naval medical research commanddept: bone marrow donor program 1133 woodglen drive, 3RD floorrockville, MD 20852
Ended Purchase Order Awarded Last action
- Contract number
- N3239825PA024
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $50,052
Award facts
- Opportunity
-
- MiSeq Silver Support 1301234383 Special Notice · N3239825QA013 · Posted Mar 26, 2025
- Contract value 24% obligated
-
- $50,052.00 Current, with exercised options
- $212,832.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- North Bethesda, MD 20852, USA
Award details come from SAM.gov/FPDS.
About this award
The Naval Medical Research Command, Bone Marrow Donor Program, awarded a $212,832 firm fixed-price purchase order to Illumina, Inc. for MiSeq Silver Support maintenance and repair services. The contract, effective through September 23, 2029, provides comprehensive coverage for parts, labor, and travel associated with the MiSeq sequencing equipment located at the Naval Medical Research Command facility in Rockville, Maryland. This award was issued without a set-aside designation, reflecting Illumina's specialized capabilities as the manufacturer of the MiSeq platform. The contract was solicited as a special notice posted on March 26, 2025, requiring a robust support plan that includes hardware and software updates, preventive maintenance, reagent replacement during failures, remote technical support, and guaranteed three-business-day average on-site response times.
Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis technologies, is well-established as a federal contractor across multiple agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, and various defense organizations. This award to the Department of the Navy's Bureau of Medicine and Surgery represents continued support for the military's genetic research and diagnostic capabilities. The MiSeq platform is a critical instrument for genomic research applications relevant to the Bone Marrow Donor Program's mission, and this extended maintenance contract ensures continuity of operations and technical support through 2029.
Quick answers
Who was awarded contract N3239825PA024?
N3239825PA024 was awarded to Illumina, Inc. by Bureau of Medicine and Surgery (Department of the Navy) on September 24, 2025.
How much is contract N3239825PA024 worth?
The government has obligated $50,052 on N3239825PA024. Its potential value, with all options, is $212,832.
Was contract N3239825PA024 competed?
The extent of competition for N3239825PA024 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award